Newsfilter article unlocker

Enter Newsfilter article ID in the field below.
Example: https://newsfilter.io/articles/39be1bef03e66cdc886c08a2a6319c47

Retrieved article

Avinger, Inc. (NASDAQ:AVGR) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET

Company Participants

Matthew Kreps - Investor Relations
Jeffrey Soinski - Chief Executive Officer
Nabeel Subainati - Principal Financial Officer

Conference Call Participants

Swayampakula Ramakanth - H.C. Wainwright

Operator

Good day, and welcome to the Avinger Third Quarter 2024 Results Conference Call. At this time, all participants are on a listen-only mode. After managements prepared remarks, there will be a question-and-answer session.

I would now like to turn the call over to Matt Kreps, Investor Relations for Avinger. The floor is yours.

Matthew Kreps

Thank you, Kelly, and thank you, everyone, for participating in today's call. I would like to welcome you to Avinger's Third Quarter 2024 Conference Call.

Joining us today are Avinger's CEO, Jeff Soinski; and Principal Financial Officer, Nabeel Subainati. Earlier today, we released the financial results for the quarter ended September 30, 2024. A copy of the release is posted on the Avinger website under Investor Relations.

Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that are not statements of historical facts should be deemed to be forward-looking statements. All forward-looking statements, including without limitation our future financial expectations, expected timing for commercial launch of products, status of our clinical sites, the expected benefits of our products, filings with the FDA and regulatory filings in China and the anticipated timing of Zylox's full manufacturing scale of our devices are based upon our current estimates and various assumptions. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by


...